PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Common transplant drug inhibits breast cancer growth, UNC laboratory study shows

2011-05-27
(Press-News.org) Tacrolimus, a drug that is commonly used to prevent organ transplantation rejection, inhibits breast cancer growth in pre-clinical studies. The finding from UNC scientists was reported in the May 26th PLoS ONE.

Nancy Klauber-DeMore, MD, associate professor of surgery, said, " We now have a rationale for performing human clinical trials to determine if Tacrolimus reduces breast cancer growth in humans. Since Tacrolimus is already an FDA-approved drug, the safety and toxicity profile is known, which means that Tacrolimus could potentially go directly into a later stage clinical trial."

Klauber-DeMore is a member of UNC Lineberger Comprehensive Cancer Center and co-founder and Chief Scientific Officer of Enci Therapeutics, Inc., a UNC spin-off biotech company. Tacrolimus is used to prevent rejection (when a person's immune system attacks of a transplanted organ by the immune system of a person receiving the organ) in people who have received kidney, liver, or heart transplants. Tacrolimus is in a class of medications called immunosuppressants. It works by decreasing the activity of the immune system to prevent it from attacking the transplanted organ. Tacrolimus does this by binding to and inactivating a protein called calcineurin in immune cells. Although preventing organ transplant rejection and inhibiting cancer growth may seem unrelated, the team realized that activating calcineurin is a common pathway that stimulates both the immune system and the growth of new blood vessels to tumors. Blocking blood vessel growth to tumors is a therapeutic strategy to inhibit tumor growth.

Klauber-DeMore's group had previously discovered that a protein called SFRP2 stimulates blood vessel growth and is expressed in human breast cancers. While investigating the mechanism through which SFRP2 stimulates blood vessel growth, they found that SFRP2 activates calcineurin in blood vessel cells. Based on this mechanism, Klauber-DeMore thought that Tacrolimus might also bind to and inactivate calcineurin in blood vessel cells, thereby blocking new blood vessel growth to tumors. The team tested this theory in a pre-clinical breast tumor model and found that orally administered Tacrolimus inhibited breast tumor growth rate by over 70 percent.

Klauber-DeMore said, "This data is encouraging, but we don't know yet whether Tacrolimus will inhibit breast cancer growth in humans. However, this pre-clinical study provides a reasoning for the next step, which will be to perform a clinical trial using Tacrolimus in patients with breast cancer."

### Side effects of Tacrolimus can be severe and include infection, cardiac damage, hypertension, blurred vision, liver, and kidney problems. Patients need to be monitored carefully and the dose is adjusted as needed.

Other authors are from the UNC School of Medicine department of surgery: Joseph Caster, PhD; Desh Bandhu Nepal, MD; and Andrew Courtwright, MD, PhD; the UNC McAllister Heart Institute: Eleanor Hilliard, BS, and Cam Patterson, MD (who is also a co-founder and President of Enci Therapeutics, Inc); and UNC Lineberger: Sharareh Siamakpour-Reihan, PhD; Jerry Usary, PhD; David Ketelsen, MA, MBA; David Darr, MS; and Xiang Jun Shen, PhD. Funding for the work was provided by University Cancer Research Fund and the National Cancer Institute.


ELSE PRESS RELEASES FROM THIS DATE:

Bruce Marks to Speak at US-Russia Business Council Forum in London

Bruce Marks to Speak at US-Russia Business Council Forum in London
2011-05-27
Leading law firm, Marks & Sokolov, is pleased to announce Managing Director, Bruce S. Marks, will moderate a prestigious panel at the 3rd US Russia Business Council Legal Forum. A world leader in US, Russian and Ukrainian law and litigation, Bruce S. Marks brings a unique and important perspective to the forum. Taking place in London on June 9th, 2011, the forum will gather the world's leading practitioners in US Russian commercial legal matters. Bruce S. Marks will moderate a panel entitled 'Legal Reform and the Courts in Russia'. It's more than two years since ...

Current test-based incentive programs have not consistently raised

2011-05-27
WASHINGTON — Despite being used for several decades, test-based incentives have not consistently generated positive effects on student achievement, says a new report from the National Research Council. The report examines evidence on incentive programs, which impose sanctions or offer rewards for students, teachers, or schools on the basis of students' test performance. Federal and state governments have increasingly relied on incentives in recent decades as a way to raise accountability in public education and in the hope of driving improvements in achievement. School-level ...

People with body-image disorders process 'big picture' visual information abnormally

2011-05-27
People suffering from body dysmorphic disorder, or BDD — a severe mental illness characterized by debilitating misperceptions that one appears disfigured and ugly — process visual information abnormally, even when looking at inanimate objects, according to a new UCLA study. First author Dr. Jamie Feusner, a UCLA assistant professor of psychiatry, and colleagues found that patients with the disorder have less brain activity when processing holistic visual elements that provide the "big picture," regardless of whether that picture is a face or an object. The research ...

5 new hot spots where medicine and technology will converge

5 new hot spots where medicine and technology will converge
2011-05-27
Medicine and technology are converging in patient care at a faster pace than most people realize. Space age advancements from point-of-care health technologies like telemedicine to medical robots performing surgery are fast becoming commonplace in many hospitals. What's next? Ask NJIT Distinguished Professor Atam Dhawan, an electrical engineer and associate dean of the NJIT Albert Dorman Honors College, chair of the the IEEE emerging technology committee, and workshop chair for the upcoming 33rd IEEE Engineering in Medicine and Biology Society (EMBS) Annual International ...

Pan American Metals Pleased to Announce Gold and Silver Once Again the 'Safe Haven' Choice

2011-05-27
Market reports May 24 showed that gold and silver had regained their standing as 'safe haven' investments, with gold remaining comfortably above the $1500 an ounce benchmark, closing the day at $1523, the highest price for three weeks. Silver has also bounced back to close, May 24, at $36.12. Mounting concerns over European debt following rumors of a Greek default helped drive investors back toward the 'safety net' of precious metals. The UK, Italy, Spain and Portugal were causing concern as they faced reduced credit ratings and, in the case of Spain, a change of government. ...

Green and lean: Secreting bacteria eliminate cost barriers for renewable biofuel production

Green and lean: Secreting bacteria eliminate cost barriers for renewable biofuel production
2011-05-27
TEMPE, Ariz.- A Biodesign Institute at Arizona State University research team has developed a process that removes a key obstacle to producing low-cost, renewable biofuels from bacteria. The team has reprogrammed photosynthetic microbes to secrete high-energy fats, making byproduct recovery and conversion to biofuels easier and potentially more commercially viable. "The real costs involved in any biofuel production are harvesting the goodies and turning them into fuel," said Roy Curtiss, of the Institute's Center for Infectious Diseases and Vaccinology and professor ...

LateRooms.com - An Evening with the Legendary John Cleese Comes to Liverpool

2011-05-27
Liverpool welcomes An Evening with the Legendary John Cleese to the Empire Theatre at the end of the month. Few comedians can claim to have had such a huge impact on the British canon of comedy as Cleese, who made his name in Monty Python's Flying Circus and Fawlty Towers. With scenes like the 'Dead Parrot Sketch' and his hilarious silly walks, the 71-year-old has become a national treasure. People heading to the show in Liverpool on May 31st can expect to enjoy his trademark sense of humour combined with insight into his long and successful career. Speaking ...

Cancer cells accelerate aging and inflammation in the body to drive tumor growth

2011-05-27
PHILADELPHIA— Researchers at the Kimmel Cancer Center at Jefferson have shed new light on the longstanding conundrum about what makes a tumor grow—and how to make it stop. Interestingly, cancer cells accelerate the aging of nearby connective tissue cells to cause inflammation, which ultimately provides "fuel" for the tumor to grow and even metastasize. This revealing symbiotic process, which is similar to how muscle and brain cells communicate with the body, could prove useful for developing new drugs to prevent and treat cancers. In this simple model, our bodies provide ...

Rendezvous with an asteroid

2011-05-27
TEMPE, Ariz. – A newly announced NASA mission to collect a sample of an asteroid and return it to Earth will include an instrument built at Arizona State University's School of Earth and Space Exploration (SESE). The ASU instrument will analyze long-wavelength infrared light emitted from the asteroid to map the minerals on its surface. The device is a modified version of the highly successful miniature infrared spectrometers carried on Spirit and Opportunity, NASA's twin Mars Exploration Rovers. The new asteroid sample-return mission is called OSIRIS-REx, an acronym standing ...

LateRooms.com - Seville to Stage Verdi's Don Carlo

2011-05-27
The Teatro de la Maestranza in Seville will stage a production of Giuseppe Verdi's Don Carlo this summer. It will be performed four times between June 24th and July 3rd with musical accompaniment by the Real Orquesta Sinfonica de Sevilla. The powerful story, which paints Spain's Phillip II as a cruel tyrant, is one of the composer's most acclaimed pieces. In Seville, Pedro Halffter takes on directorial duties, while the cast is led by Fiorenza Cedolins, Dolora Zajick and Walter Fraccaro as the titular character. The plot revolves around Don Carlo's wife-to-be ...

LAST 30 PRESS RELEASES:

Sensing sickness

Cost to build multifamily housing in California more than twice as high as in Texas

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

The experts that can outsmart optical illusions

Pregnancy may reduce long COVID risk

[Press-News.org] Common transplant drug inhibits breast cancer growth, UNC laboratory study shows